Treatment patterns of patients with BRAF-mutant metastatic colorectal cancer: Results from the German Tumor Registry Colorectal Cancer (TKK Registry)

被引：0
|
作者：
Zahn, M. -O. [1 ]
Doerfel, S. [2 ]
Schnell, R.
Wolf, T. [3 ]
Vehling-Kaiser, U. [4 ]
Kruggel, L. [5 ]
Jaenicke, M. [5 ]
Wetzel, N. [5 ]
Marschner, N.
机构：
[1] Studienzentrum MVZ Onkol Kooperat Harz, Goslar, Germany
[2] Onkozentrum Dresden Freiberg, Dresden, Germany
[3] BAG Onkol Gemeinschaftspraxis, Dresden, Germany
[4] Hamatologisch Onkol Tagesklin, Landshut, Germany
[5] iOMEDICO, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158
引用
下载
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [21] Hitting the Target in BRAF-Mutant Colorectal Cancer
    Nagaraja, Ankur K.
    Bass, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 3990 - +
  • [22] Targeted therapy for BRAF-mutant colorectal cancer
    Gunjur, Ashray
    LANCET ONCOLOGY, 2019, 20 (11): : E618 - E618
  • [23] Clinicopathologic features and impact of metastasectomy in patients with BRAF-mutant metastatic colorectal cancer.
    Zhang, Jianwei
    Shen, Cailu
    Li, Jianxia
    Wu, Zehua
    Hu, Huabin
    Cai, Yue
    Xie, Xiaoyu
    Ling, Jiayu
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] FOLFOXIRI plus bevacizumab as first-line treatment of BRAF-mutant metastatic colorectal cancer patients
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Masi, Gianluca
    Antoniotti, Carlotta
    Fornaro, Lorenzo
    Sensi, Elisa
    Lupi, Cristiana
    Bergamo, Francesca
    Lonardi, Sara
    Zagonel, Vittorina
    Fontanini, Gabriella
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Systemic palliative treatment and outcome in later lines in patients with metastatic colorectal cancer - Real-life data from the clinical Tumour Registry Colorectal Cancer (TKK)
    Schnell, R.
    Uhlig, J.
    Eggers, E.
    Jaenicke, M.
    Fleitz, A.
    Wetzel, N.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 167 - 167
  • [26] Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer
    Rodriquenz, Maria Grazia
    Ciardiello, Davide
    Latiano, Tiziana Pia
    Maiorano, Brigida Anna
    Martinelli, Erika
    Silvestris, Nicola
    Ciardiello, Fortunato
    Maiello, Evaristo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 173
  • [27] Molecular targeted therapy of BRAF-mutant colorectal cancer
    Ducreux, Michel
    Chamseddine, Ali
    Laurent-Puig, Pierre
    Smolenschi, Cristina
    Hollebecque, Antoine
    Dartigues, Peggy
    Samallin, Emmanuelle
    Boige, Valerie
    Malka, David
    Gelli, Maximiliano
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [28] Kinase Inhibitor in a Patient with BRAF-mutant Colorectal Cancer
    Sakumura, Miho
    Ando, Takayuki
    Ueda-Consolvo, Tomoko
    Motoo, Iori
    Mihara, Hiroshi
    Kajiura, Shinya
    Teramoto, Akira
    Nanjo, Sohachi
    Fujinami, Haruka
    Yasuda, Ichiro
    INTERNAL MEDICINE, 2022, 61 (11) : 1707 - 1712
  • [29] BRAF-mutant colorectal cancer, a different breed evolving
    Lai, Eleonora
    Pretta, Andrea
    Impera, Valentino
    Mariani, Stefano
    Giampieri, Riccardo
    Casula, Laura
    Pusceddu, Valeria
    Coni, Pierpaolo
    Fanni, Daniela
    Puzzoni, Marco
    Demurtas, Laura
    Ziranu, Pina
    Faa, Gavino
    Scartozzi, Mario
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (06) : 499 - 512
  • [30] Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
    Li Chia Chong
    Amanda Rose Townsend
    Joanne Young
    Amitesh Roy
    Cynthia Piantadosi
    Jennifer E. Hardingham
    David Roder
    Christos Karapetis
    Robert Padbury
    Guy Maddern
    James Moore
    Timothy Jay Price
    Targeted Oncology, 2019, 14 : 85 - 91
12345